Tardive Dyskinesia Treatment MarketPosted by ahila on May 1st, 2018 Global Tardive Dyskinesia Treatment Market :Tardive dyskinesia is a movement disorder which develops with long duration compliance to antipsychotic drugs. This is characterised primarily by random movements of tongue, jaws, lips and different muscles sometimes even with fingers, toes and legs. In sever conditions of tardive dyskinesia patients may experience heaving breathing associated with trunk or hips or muscles swaying movements. It is a long-term cause of neuroleptic drugs which are more often prescribed for certain mental, neurological or GI disorders. Growing prevalence of patients suffering from various neurological disorders is the major factor driving the market growth of TD treatment. For example, In 2017 April, Neurocrine Biosciences has published a report which stated that about 5lakhs people are suffering from TD in U.S. Tardive dyskinesia treatment market is anticipated to grow significantly during the forecast period owing to rise in geriatric population, busy and tense lifestyle, growing prescription of anti-psychotic drugs etc. The factors which are hampering the growth TD market is approval process of new treatment approaches by respective governments, delayed diagnosis of the disease and lack of awareness regarding the disease. A sample of this report is available upon request @ The tardive dyskinesia treatment market is classified on the basis of drug class, infection type distribution channel, and geography. Based on drug class, the tardive dyskinesia treatment market is segmented into the following
Based on route of administration, the tardive dyskinesia treatment market is segmented into the following
Based on distribution channel, the tardive dyskinesia treatment market is segmented into the following
To view TOC of this report is available upon request @ Like it? Share it! More by this author |